Kami Maddocks
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT02950220) | Kami Maddocks | 2017-01-12 |
Track Kami Maddocks automatically
Every clearance here is in the API, with alerts when new ones post.